IP Library Assignment 028243/0255
Patent Assignment
Reel/Frame 028243/0255

Assignment of Assignor's Interest

Recorded: 2012-05-21 Pages: 2
Assignor
ARGENTA DISCOVERY 2009 LIMITED
Executed: 2012-05-09
Assignee
GENENTECH, INC.
1 DNA WAY, MS: 49, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Property (1)
Tricyclic PI3K Inhibitor Compounds and Methods of Use
Patent: 8,883,799 →
Application: 13/326,524 →
Publication: US 2012/0171199
Related Assignments (6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest May 21, 2012
From: DOTSON, JENNAFER; HEFFRON, TIMOTHY; NDUBAKU, CHUDI; OLIVERO, ALAN G.
To: GENENTECH, INC.
Reel/Frame 028243/0062 →
Assignment of Assignor's Interest May 21, 2012
From: HEALD, ROBERT A.; JONES, GRAHAM E.; KRINTEL, SUSSIE L.; MCLEAN, NEVILLE J.
To: ARGENTA DISCOVERY 2009 LIMITED
Reel/Frame 028243/0198 →
Assignment of Assignor's Interest Jun 15, 2012
From: GENENTECH, INC.
To: F. HOFFMANN-LA ROCHE AG
Reel/Frame 028382/0857 →
Assignment of Assignor's Interest Aug 31, 2016
From: F. HOFFMANN-LA ROCHE AG
To: GENENTECH, INC.
Reel/Frame 039602/0394 →
License Nov 13, 2020
From: GENENTECH, INC.
To: NOVOGEN LIMITED
Reel/Frame 054402/0865 →
Change of Name Nov 13, 2020
From: NOVOGEN LIMITED
To: KAZIA THERAPEUTICS LIMITED
Reel/Frame 054409/0200 →